CIXING(SZ:300307)2023-10-26 16:00Financial Performance - The company's operating revenue for Q3 2023 was ¥454,952,267.78, representing a year-on-year increase of 4.80%[5] - Net profit attributable to shareholders for Q3 2023 reached ¥21,795,281.34, a significant increase of 68.68% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥9,910,893.22, up by 3,808.00% year-on-year[5] - Basic and diluted earnings per share for Q3 2023 were both ¥0.0279, reflecting a growth of 39.50% compared to the previous year[5] - The net profit for the third quarter of 2023 was CNY 120,344,042.17, an increase from CNY 81,046,790.43 in the same period last year, representing a growth of approximately 48.5%[22] - Operating profit for the third quarter was CNY 124,205,343.77, compared to CNY 82,865,721.23 in the previous year, indicating a year-over-year increase of about 50%[22] - The company reported a total comprehensive income of CNY 121,880,454.87 for the third quarter, compared to CNY 82,593,084.28 in the previous year, reflecting a growth of around 47.5%[22] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥134,977,664.49, showing a substantial increase of 222.15%[5] - The net cash flow from operating activities improved significantly to CNY 134,977,664.49, a 222.15% increase from a negative CNY 110,505,267.68 in the previous year[11] - Cash flow from operating activities generated a net amount of CNY 134,977,664.49, a significant improvement from a negative cash flow of CNY -110,505,267.68 in the same period last year[23] - The net cash flow from investing activities was CNY 53,590,043.05, a recovery from a negative cash flow of CNY -28,923,091.12 in the previous year[23] Assets and Liabilities - Total assets at the end of Q3 2023 amounted to ¥4,655,977,341.26, marking a 5.32% increase from the end of the previous year[5] - The company's total revenue for the current period was CNY 1,720,027,809.67, up from CNY 1,541,845,953.55 in the previous period, representing an increase of about 11.6%[20] - The total liabilities increased to CNY 1,795,923,246.61 from CNY 1,710,346,705.15, an increase of about 5.0%[19] - The company's equity attributable to shareholders rose to CNY 2,896,398,972.71 from CNY 2,750,393,270.02, an increase of approximately 5.3%[19] Receivables and Payables - Accounts receivable decreased by 7.79% from the beginning of the year, amounting to ¥705,967,568.35[10] - The company reported a 28.54% decrease in notes receivable, totaling ¥7,362,916.00[10] - Accounts receivable decreased to CNY 705,967,568.35 from CNY 765,599,251.27, a decline of approximately 7.8%[17] - The company’s total liabilities included accounts payable of CNY 501,578,182.06, reflecting a 9.67% increase from CNY 457,352,000.57[11] Expenses and Investments - Research and development expenses decreased by 21.44% to CNY 36,444,048.25, down from CNY 46,387,650.29 year-on-year[11] - Investment income rose by 52.84% to CNY 12,984,820.55, primarily due to gains from equity transfers of associated companies[11] - The company’s financial expenses decreased significantly by 65.31% to a negative CNY 6,372,470.79, mainly due to the impact of exchange rate fluctuations[11] Cash and Equivalents - Cash and cash equivalents rose to CNY 833,469,155.00 from CNY 556,640,044.45, an increase of about 49.6%[17] - Cash and cash equivalents at the end of the period totaled CNY 355,083,530.26, compared to CNY 134,703,628.99 at the end of the previous year, showing a significant increase[24] - The company reported a significant increase in cash and cash equivalents, totaling CNY 185,209,300.86, a 352.58% rise from a negative CNY 73,327,996.07 in the same period last year[11]